This session will explore the critical role of neonatal nutrition in the prevention and management of pediatric dermatological conditions. Emphasis will be placed on the relationship between nutritional deficiencies and skin disorders in infants.

This track will focus on the immunological mechanisms underlying various genodermatoses in pediatric patients. Discussions will include genetic predispositions and their implications for treatment strategies.

This session will highlight recent advancements in the treatment of acne among children and adolescents. It will cover both pharmacological and non-pharmacological approaches, with a focus on safety and efficacy.

This track will address the prevalence and management of viral skin infections in pediatric patients. Participants will discuss diagnostic challenges and therapeutic options, including antiviral treatments.

This session will examine the immunological responses to various skin infections in children. The focus will be on understanding how immune system variations affect susceptibility and treatment outcomes.

This track will provide insights into the epidemiology and management of bacterial and fungal skin infections in pediatric dermatology. Emphasis will be placed on emerging resistance patterns and treatment protocols.

This session will discuss the unique aspects of melanoma in pediatric patients, including risk factors and early detection strategies. The focus will also be on innovative treatment approaches and outcomes.

This track will delve into the immunological underpinnings of pediatric atopic dermatitis. Discussions will include the role of allergens, skin barrier dysfunction, and emerging therapies.

This session will explore the relationship between endocrine disorders, such as thyroid disease and diabetes, and their impact on skin health in children. The focus will be on diagnosis, management, and interdisciplinary approaches.

This track will highlight the role of technology in the management of Type 1 and Type 2 diabetes in pediatric populations. Discussions will include the use of continuous glucose monitoring and insulin delivery systems.

This session will address the impact of growth disorders on skin health in children. Participants will discuss the interplay between growth abnormalities and dermatological conditions, focusing on management strategies.